Genetic characterization of breast cancer and implications for clinical management

Felipe C Geyer ¹, Maria A Lopez-Garcia , Maryou B Lambros , Jorge S Reis-Filho

Affiliations

¹ Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

PMID: 19754664
172 References
7 citations

Abstract

Breast cancer is a genetic disease caused by the accumulation of mutations in neoplastic cells. In the last few years, high-throughput microarray-based molecular analysis has provided increasingly more coherent information about the genetic aberrations in breast cancer. New biomarkers and molecular techniques are slowly becoming part of the diagnostic and prognostic armamentarium available for pathologists and oncologists to tailor the therapy for breast cancer patients. In this review, we will focus on the contribution of breast cancer somatic genetics to our understanding of breast cancer biology and its impact on breast cancer patient management.

Other Links

Free PMC article
Full text on Journal of cellular and molecular medicine

References
Cited By

References
Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. José Palacios, Emiliano Honrado, +11 authors, Javier Benítez. less Breast Cancer Res Treat, 2005 Mar 17; 90(1). PMID: 15770521
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. A Bergamaschi, E Tagliabue, +10 authors, A-L Børresen-Dale. less J Pathol, 2007 Nov 30; 214(3). PMID: 18044827 Highly Cited.
Stromal gene expression predicts clinical outcome in breast cancer. Greg Finak, Nicholas Bertos, +9 authors, Morag Park. less Nat Med, 2008 Apr 29; 14(5). PMID: 18438415 Highly Cited.
Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Tarek M A Abdel-Fatah, Desmond G Powe, +3 authors, Ian O Ellis. less Am J Surg Pathol, 2008 Jan 29; 32(4). PMID: 18223478
The cancer genome. Michael R Stratton, Peter J Campbell, P Andrew Futreal. Nature, 2009 Apr 11; 458(7239). PMID: 19360079 Free PMC article. Highly Cited. Review.
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Fabrice Andre, Bastien Job, +12 authors, Lajos Pusztai. less Clin Cancer Res, 2009 Jan 17; 15(2). PMID: 19147748 Highly Cited.
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. H B Muss, A D Thor, +7 authors, M Barcos. less N Engl J Med, 1994 May 05; 330(18). PMID: 7908410 Highly Cited.
retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group. Ann S Knoop, Helle Knudsen, +9 authors, Danish Breast Cancer Cooperative Group. less J Clin Oncol, 2005 Oct 20; 23(30). PMID: 16234514
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401. Scandinavian Breast Group Trial 9401, Minna Tanner, +7 authors, Jonas Bergh. less J Clin Oncol, 2006 May 10; 24(16). PMID: 16682728
WIP1 phosphatase is a negative regulator of NF-kappaB signalling. Joanne Chew, Subhra Biswas, +9 authors, Vinay Tergaonkar. less Nat Cell Biol, 2009 Apr 21; 11(5). PMID: 19377466
A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D. S Rayter, R Elliott, +9 authors, A Ashworth. less Oncogene, 2007 Aug 19; 27(8). PMID: 17700519
Interactive effects of inhibitors of poly(ADP-ribose) polymerase and DNA-dependent protein kinase on cellular responses to DNA damage. S Boulton, S Kyle, B W Durkacz. Carcinogenesis, 1999 Mar 09; 20(2). PMID: 10069454
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Jason I Herschkowitz, Karl Simin, +23 authors, Charles M Perou. less Genome Biol, 2007 May 12; 8(5). PMID: 17493263 Free PMC article. Highly Cited.
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Jorge Sergio Reis-Filho, Pete T Simpson, +15 authors, Alan Ashworth. less Clin Cancer Res, 2006 Nov 24; 12(22). PMID: 17121884
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. Martine J Piccart-Gebhart, Marion Procter, +30 authors, Herceptin Adjuvant (HERA) Trial Study Team. less N Engl J Med, 2005 Oct 21; 353(16). PMID: 16236737 Highly Cited.
Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer. Laura Orlando, Barbara Del Curto, +10 authors, Marco Colleoni. less Breast, 2008 May 06; 17(5). PMID: 18456496
Hereditary breast cancer: from molecular pathology to tailored therapies. D S P Tan, C Marchiò, J S Reis-Filho. J Clin Pathol, 2008 Aug 07; 61(10). PMID: 18682420 Review.
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. C B Vos, A M Cleton-Jansen, +6 authors, M J van de Vijver. less Br J Cancer, 1997 Jan 01; 76(9). PMID: 9365159 Free PMC article.
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. E A Rakha, T C Putti, +6 authors, I O Ellis. less J Pathol, 2006 Jan 24; 208(4). PMID: 16429394
Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event. I-Tien Yeh, Mathew A Martin, +6 authors, Shelly R Gunn. less Mod Pathol, 2009 May 19; 22(9). PMID: 19448591
E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Anne-Marie Cleton-Jansen. Breast Cancer Res, 2002 Mar 07; 4(1). PMID: 11879552 Free PMC article. Review.
ETV6 gene rearrangements in invasive breast carcinoma. Anne Letessier, Christophe Ginestier, +8 authors, Max Chaffanet. less Genes Chromosomes Cancer, 2005 May 12; 44(1). PMID: 15887243
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Chad A Livasy, Gamze Karaca, +4 authors, Charles M Perou. less Mod Pathol, 2005 Dec 13; 19(2). PMID: 16341146 Highly Cited.
Trastuzumab: triumphs and tribulations. R Nahta, F J Esteva. Oncogene, 2007 May 29; 26(25). PMID: 17530017 Highly Cited. Review.
DNA topoisomerases: structure, function, and mechanism. J J Champoux. Annu Rev Biochem, 2001 Jun 08; 70. PMID: 11395412 Highly Cited. Review.
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Torsten O Nielsen, Forrest D Hsu, +13 authors, Charles M Perou. less Clin Cancer Res, 2004 Aug 26; 10(16). PMID: 15328174 Highly Cited.
Breast cancer special types: why bother? J S Reis-Filho, S R Lakhani. J Pathol, 2008 Sep 18; 216(4). PMID: 18798222
Supervised risk predictor of breast cancer based on intrinsic subtypes. Joel S Parker, Michael Mullins, +17 authors, Philip S Bernard. less J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204204 Free PMC article. Highly Cited.
Copy number alterations that predict metastatic capability of human breast cancer. Yi Zhang, John W M Martens, +6 authors, John A Foekens. less Cancer Res, 2009 Apr 02; 69(9). PMID: 19336569
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. S Paik, J Bryant, +7 authors, N Wolmark. less J Natl Cancer Inst, 1998 Sep 25; 90(18). PMID: 9747867
ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism. Anne-Marie Cleton-Jansen, Ronald van Eijk, +8 authors, Cees J Cornelisse. less BMC Cancer, 2008 Apr 18; 8. PMID: 18416817 Free PMC article.
Molecular evolution of breast cancer. Peter T Simpson, Jorge S Reis-Filho, Theodora Gale, Sunil R Lakhani. J Pathol, 2005 Jan 11; 205(2). PMID: 15641021 Highly Cited. Review.
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Laurel A Habel, Steven Shak, +12 authors, Charles P Quesenberry. less Breast Cancer Res, 2006 Jun 02; 8(3). PMID: 16737553 Free PMC article. Highly Cited.
Molecular portraits of human breast tumours. C M Perou, T Sørlie, +15 authors, D Botstein. less Nature, 2000 Aug 30; 406(6797). PMID: 10963602 Highly Cited.
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Koei Chin, Sandy DeVries, +21 authors, Joe W Gray. less Cancer Cell, 2006 Dec 13; 10(6). PMID: 17157792 Highly Cited.
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Isabelle Bernard-Pierrot, Nadège Gruel, +7 authors, Olivier Delattre. less Cancer Res, 2008 Sep 02; 68(17). PMID: 18757432
Gene expression profiling predicts clinical outcome of breast cancer. Laura J van 't Veer, Hongyue Dai, +13 authors, Stephen H Friend. less Nature, 2002 Feb 02; 415(6871). PMID: 11823860 Highly Cited.
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis. Somaia Elbauomy Elsheikh, Andrew R Green, +5 authors, Jorge S Reis-Filho. less Breast Cancer Res, 2007 Apr 03; 9(2). PMID: 17397528 Free PMC article.
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Antonio C Wolff, M Elizabeth H Hammond, +22 authors, College of American Pathologists. less J Clin Oncol, 2006 Dec 13; 25(1). PMID: 17159189 Highly Cited.
Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic? Hervé Bonnefoi, Craig Underhill, Richard Iggo, David Cameron. Eur J Cancer, 2009 May 30; 45(10). PMID: 19477634 Review.
The molecular portraits of breast tumors are conserved across microarray platforms. Zhiyuan Hu, Cheng Fan, +28 authors, Charles M Perou. less BMC Genomics, 2006 Apr 29; 7. PMID: 16643655 Free PMC article. Highly Cited.
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. Edward H Romond, Edith A Perez, +22 authors, Norman Wolmark. less N Engl J Med, 2005 Oct 21; 353(16). PMID: 16236738 Highly Cited.
The impact of expression profiling on prognostic and predictive testing in breast cancer. J S Reis-Filho, C Westbury, J-Y Pierga. J Clin Pathol, 2006 Mar 01; 59(3). PMID: 16505270 Free PMC article. Review.
Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial. S Mook, H Bonnefoi, +7 authors, E J Rutgers. less Eur J Cancer, 2009 Feb 24; 45(7). PMID: 19232484
The prognostic role of a gene signature from tumorigenic breast-cancer cells. Rui Liu, Xinhao Wang, +7 authors, Michael F Clarke. less N Engl J Med, 2007 Jan 19; 356(3). PMID: 17229949 Highly Cited.
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cristina Tognon, Stevan R Knezevich, +9 authors, Poul H B Sorensen. less Cancer Cell, 2002 Nov 27; 2(5). PMID: 12450792 Highly Cited.
Determination of stromal signatures in breast carcinoma. Robert B West, Dimitry S A Nuyten, +11 authors, Matt van de Rijn. less PLoS Biol, 2005 May 05; 3(6). PMID: 15869330 Free PMC article.
Evaluation of biological pathways involved in chemotherapy response in breast cancer. Attila Tordai, Jing Wang, +6 authors, Lajos Pusztai. less Breast Cancer Res, 2008 May 01; 10(2). PMID: 18445275 Free PMC article.
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. C Marchiò, M Iravani, +13 authors, J S Reis-Filho. less J Pathol, 2008 May 20; 215(4). PMID: 18484683
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). Jolien M Bueno-de-Mesquita, Wim H van Harten, +19 authors, Sabine C Linn. less Lancet Oncol, 2007 Nov 29; 8(12). PMID: 18042430
Comparison of prognostic gene expression signatures for breast cancer. Benjamin Haibe-Kains, Christine Desmedt, +6 authors, Christos Sotiriou. less BMC Genomics, 2008 Aug 23; 9. PMID: 18717985 Free PMC article.
Non-operative breast pathology: lobular neoplasia. Jorge S Reis-Filho, Sarah E Pinder. J Clin Pathol, 2006 Dec 22; 60(12). PMID: 17182661 Free PMC article. Review.
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Pratyaksha Wirapati, Christos Sotiriou, +10 authors, Mauro Delorenzi. less Breast Cancer Res, 2008 Jul 30; 10(4). PMID: 18662380 Free PMC article. Highly Cited.
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Helen E Bryant, Niklas Schultz, +7 authors, Thomas Helleday. less Nature, 2005 Apr 15; 434(7035). PMID: 15829966 Highly Cited.
Repeated observation of breast tumor subtypes in independent gene expression data sets. Therese Sorlie, Robert Tibshirani, +13 authors, David Botstein. less Proc Natl Acad Sci U S A, 2003 Jun 28; 100(14). PMID: 12829800 Free PMC article. Highly Cited.
Basal-like breast cancer and the BRCA1 phenotype. N C Turner, J S Reis-Filho. Oncogene, 2006 Sep 26; 25(43). PMID: 16998499 Highly Cited. Review.
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy. Judith A Gilbert, Matthew P Goetz, +9 authors, Matthew M Ames. less Mol Cancer Ther, 2008 Apr 17; 7(4). PMID: 18413808 Free PMC article.
Chromosome 16 tumor-suppressor genes in breast cancer. Emad A Rakha, Andrew R Green, +2 authors, Des G Powe, Rebecca Roylance, Ian O Ellis. less Genes Chromosomes Cancer, 2006 Mar 07; 45(6). PMID: 16518845 Review.
Targeting the DNA repair defect of BRCA tumours. Nicholas Turner, Andrew Tutt, Alan Ashworth. Curr Opin Pharmacol, 2005 Jun 16; 5(4). PMID: 15955736 Review.
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. M Fiscella, H Zhang, +6 authors, E Appella. less Proc Natl Acad Sci U S A, 1997 Jun 10; 94(12). PMID: 9177166 Free PMC article. Highly Cited.
Trastuzumab--mechanism of action and use in clinical practice. Clifford A Hudis. N Engl J Med, 2007 Jul 06; 357(1). PMID: 17611206 Highly Cited. Review.
Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. E Honrado, A Osorio, J Palacios, J Benitez. Oncogene, 2006 Sep 26; 25(43). PMID: 16998498 Review.
Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis. Yun Xia, Pat Ongusaha, Sam W Lee, Yih-Cherng Liou. J Biol Chem, 2009 Apr 28; 284(26). PMID: 19395378 Free PMC article.
Histopathology of BRCA1- and BRCA2-associated breast cancer. Emiliano Honrado, Javier Benítez, José Palacios. Crit Rev Oncol Hematol, 2006 Mar 15; 59(1). PMID: 16530420 Review.
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. Peter C Fong, David S Boss, +12 authors, Johann S de Bono. less N Engl J Med, 2009 Jun 26; 361(2). PMID: 19553641 Highly Cited.
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. H Fujimoto, N Onishi, +8 authors, Y Minami. less Cell Death Differ, 2005 Nov 29; 13(7). PMID: 16311512
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. David Sarrió, Gema Moreno-Bueno, +6 authors, José Palacios. less Int J Cancer, 2003 Jun 12; 106(2). PMID: 12800196
Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase. Sathyavageeswaran Shreeram, Weng Kee Hee, +6 authors, Dmitry V Bulavin. less J Exp Med, 2006 Dec 13; 203(13). PMID: 17158963 Free PMC article.
Basal-like breast cancer: a critical review. Emad A Rakha, Jorge S Reis-Filho, Ian O Ellis. J Clin Oncol, 2008 May 20; 26(15). PMID: 18487574 Highly Cited. Review.
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Bryan T Hennessy, Ana-Maria Gonzalez-Angulo, +24 authors, Gordon B Mills. less Cancer Res, 2009 May 14; 69(10). PMID: 19435916 Free PMC article. Highly Cited.
Concordance among gene-expression-based predictors for breast cancer. Cheng Fan, Daniel S Oh, +5 authors, Charles M Perou. less N Engl J Med, 2006 Aug 11; 355(6). PMID: 16899776 Highly Cited.
A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Nikita Makretsov, May He, +4 authors, David G Huntsman. less Genes Chromosomes Cancer, 2004 Apr 22; 40(2). PMID: 15101049
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study. David G Hicks, Brian J Yoder, +7 authors, Raymond R Tubbs. less Hum Pathol, 2005 May 14; 36(4). PMID: 15891995
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials. Alessandra Gennari, Maria Pia Sormani, +4 authors, Paolo Bruzzi. less J Natl Cancer Inst, 2007 Dec 27; 100(1). PMID: 18159072
BRCA2-dependent and independent formation of RAD51 nuclear foci. Madalena Tarsounas, Derek Davies, Stephen C West. Oncogene, 2003 Feb 28; 22(8). PMID: 12606939
Are triple-negative tumours and basal-like breast cancer synonymous? Emad A Rakha, David S P Tan, +4 authors, Jorge S Reis-Filho. less Breast Cancer Res, 2008 Feb 19; 9(6). PMID: 18279542 Free PMC article.
Cancer: crossing over to drug resistance. David M Livingston, Daniel P Silver. Nature, 2008 Feb 29; 451(7182). PMID: 18305536
Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Emad A Rakha, Somaia E Elsheikh, +12 authors, Ian O Ellis. less Clin Cancer Res, 2009 Mar 26; 15(7). PMID: 19318481 Highly Cited.
DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: current data and issues on study design. Fabrice Andre, Chafika Mazouni, Gabriel N Hortobagyi, Lajos Pusztai. Biochim Biophys Acta, 2006 Sep 12; 1766(2). PMID: 16962247 Review.
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Wataru Sakai, Elizabeth M Swisher, +9 authors, Toshiyasu Taniguchi. less Nature, 2008 Feb 12; 451(7182). PMID: 18264087 Free PMC article. Highly Cited.
A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. Alan Ashworth. J Clin Oncol, 2008 Jul 02; 26(22). PMID: 18591545 Highly Cited. Review.
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Xiao-Jun Ma, Zuncai Wang, +27 authors, Dennis C Sgroi. less Cancer Cell, 2004 Jun 15; 5(6). PMID: 15193263 Highly Cited.
Resistance to therapy caused by intragenic deletion in BRCA2. Stacey L Edwards, Rachel Brough, +6 authors, Alan Ashworth. less Nature, 2008 Feb 12; 451(7182). PMID: 18264088 Highly Cited.
Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Rachael Natrajan, Maryou B Lambros, +19 authors, Jorge S Reis-Filho. less Clin Cancer Res, 2009 Mar 26; 15(8). PMID: 19318498
Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes. J S Reis-Filho, R Natrajan, +7 authors, I O Ellis. less Histopathology, 2008 May 09; 52(7). PMID: 18462362
Refinement of breast cancer classification by molecular characterization of histological special types. B Weigelt, H M Horlings, +7 authors, J L Peterse. less J Pathol, 2008 Aug 23; 216(2). PMID: 18720457 Highly Cited.
Modelling breast cancer: one size does not fit all. Tracy Vargo-Gogola, Jeffrey M Rosen. Nat Rev Cancer, 2007 Aug 28; 7(9). PMID: 17721431 Highly Cited. Review.
High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Tarek M A Abdel-Fatah, Desmond G Powe, +3 authors, Ian O Ellis. less Am J Surg Pathol, 2007 Feb 28; 31(3). PMID: 17325484
Do 'basal-like' breast cancers really exist? Barry Gusterson. Nat Rev Cancer, 2009 Jan 10; 9(2). PMID: 19132008 Review.
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis. Caterina Marchiò, Maryou B Lambros, +11 authors, Anna Sapino. less J Pathol, 2009 Aug 12; 219(1). PMID: 19670217
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Bas Kreike, Marieke van Kouwenhove, +4 authors, Marc J van de Vijver. less Breast Cancer Res, 2007 Oct 04; 9(5). PMID: 17910759 Free PMC article. Highly Cited.
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Anna Bergamaschi, Young H Kim, +6 authors, Jonathan R Pollack. less Genes Chromosomes Cancer, 2006 Aug 10; 45(11). PMID: 16897746 Highly Cited.
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Sunil R Lakhani, Jorge S Reis-Filho, +34 authors, Breast Cancer Linkage Consortium. less Clin Cancer Res, 2005 Jul 22; 11(14). PMID: 16033833 Highly Cited.
Integrated profiling of basal and luminal breast cancers. José Adélaïde, Pascal Finetti, +13 authors, Max Chaffanet. less Cancer Res, 2007 Dec 20; 67(24). PMID: 18089785 Highly Cited.
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark. less J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680 Highly Cited.
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Matt van de Rijn, Charles M Perou, +13 authors, Pat Brown. less Am J Pathol, 2002 Dec 06; 161(6). PMID: 12466114 Free PMC article. Highly Cited.
Comparison of gene sets for expression profiling: prediction of metastasis from low-malignant breast cancer. Mads Thomassen, Qihua Tan, +3 authors, Torben A Kruse. less Clin Cancer Res, 2007 Sep 19; 13(18 Pt 1). PMID: 17875763
Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Barry A Gusterson, Douglas T Ross, Victoria J Heath, Torsten Stein. Breast Cancer Res, 2005 Jul 01; 7(4). PMID: 15987465 Free PMC article. Review.
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines. Edurne Arriola, Caterina Marchio, +11 authors, Jorge S Reis-Filho. less Lab Invest, 2008 Mar 12; 88(5). PMID: 18332872
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark. less N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335 Highly Cited.
Triple negative tumours: a critical review. J S Reis-Filho, A N J Tutt. Histopathology, 2008 Jan 04; 52(1). PMID: 18171422 Highly Cited. Review.
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Yixin Wang, Jan G M Klijn, +11 authors, John A Foekens. less Lancet, 2005 Feb 22; 365(9460). PMID: 15721472 Highly Cited.
Novel patterns of genome rearrangement and their association with survival in breast cancer. James Hicks, Alexander Krasnitz, +20 authors, Anders Zetterberg. less Genome Res, 2006 Dec 05; 16(12). PMID: 17142309 Free PMC article. Highly Cited.
Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Britta Weigelt, Bas Kreike, Jorge S Reis-Filho. Breast Cancer Res Treat, 2008 Sep 26; 117(2). PMID: 18815879
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Leah M Prentice, Ashleen Shadeo, +14 authors, David G Huntsman. less Oncogene, 2005 Jul 20; 24(49). PMID: 16027731
Comparative genomic hybridisation arrays: high-throughput tools to determine targeted therapy in breast cancer. David S P Tan, Jorge S Reis-Filho. Pathobiology, 2008 Jun 12; 75(2). PMID: 18544961 Review.
Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Christos Sotiriou, Martine J Piccart. Nat Rev Cancer, 2007 Jun 23; 7(7). PMID: 17585334 Highly Cited. Review.
A mouse model of basal-like breast carcinoma with metaplastic elements. A McCarthy, K Savage, +3 authors, A Gabriel, C Naceur, J S Reis-Filho, A Ashworth. less J Pathol, 2007 Jan 11; 211(4). PMID: 17212342
Breast cancer: origins and evolution. Kornelia Polyak. J Clin Invest, 2007 Nov 03; 117(11). PMID: 17975657 Free PMC article. Highly Cited. Review.
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. S R Lakhani, J Jacquemier, +38 authors, D F Easton. less J Natl Cancer Inst, 1998 Aug 13; 90(15). PMID: 9701363 Highly Cited.
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Dmitry V Bulavin, Crissy Phillips, +5 authors, Albert J Fornace. less Nat Genet, 2004 Mar 03; 36(4). PMID: 14991053 Highly Cited.
Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Laurent Perreard, Cheng Fan, +18 authors, Philip S Bernard. less Breast Cancer Res, 2006 Apr 22; 8(2). PMID: 16626501 Free PMC article.
Molecular classification and molecular forecasting of breast cancer: ready for clinical application? James D Brenton, Lisa A Carey, Ahmed Ashour Ahmed, Carlos Caldas. J Clin Oncol, 2005 Sep 08; 23(29). PMID: 16145060 Highly Cited. Review.
Comprehensive profiling of 8p11-12 amplification in breast cancer. Véronique Gelsi-Boyer, Béatrice Orsetti, +20 authors, Max Chaffanet. less Mol Cancer Res, 2005 Dec 29; 3(12). PMID: 16380503
Metaplastic breast carcinomas are basal-like tumours. J S Reis-Filho, F Milanezi, +6 authors, F C Schmitt. less Histopathology, 2006 Jul 18; 49(1). PMID: 16842242
Expression of luminal and basal cytokeratins in human breast carcinoma. Dalia M Abd El-Rehim, Sarah E Pinder, +5 authors, Ian O Ellis. less J Pathol, 2004 May 14; 203(2). PMID: 15141381 Highly Cited.
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. Sunil R Lakhani, Marc J Van De Vijver, +4 authors, Douglas F Easton. less J Clin Oncol, 2002 May 01; 20(9). PMID: 11981002 Highly Cited.
BRCA1, a potential predictive biomarker in the treatment of breast cancer. Colin R James, Jennifer E Quinn, +2 authors, Paul B Mullan, Patrick G Johnston, D Paul Harkin. less Oncologist, 2007 Feb 14; 12(2). PMID: 17296808 Review.
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Xiaoling Liu, Henne Holstege, +9 authors, Jos Jonkers. less Proc Natl Acad Sci U S A, 2007 Jul 13; 104(29). PMID: 17626182 Free PMC article. Highly Cited.
Bringing DNA repair in tumors into focus. Christopher J Lord, Alan Ashworth. Clin Cancer Res, 2009 May 19; 15(10). PMID: 19447863
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. D J Slamon, B Leyland-Jones, +9 authors, L Norton. less N Engl J Med, 2001 Mar 15; 344(11). PMID: 11248153 Highly Cited.
Gene-expression signatures in breast cancer. Christos Sotiriou, Lajos Pusztai. N Engl J Med, 2009 Feb 21; 360(8). PMID: 19228622 Highly Cited. Review.
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer. Andrew E Teschendorff, Carlos Caldas. Breast Cancer Res, 2008 Aug 30; 10(4). PMID: 18755024 Free PMC article.
DNA copy number alterations and expression of relevant genes in triple-negative breast cancer. Wonshik Han, Eun-Mi Jung, +10 authors, Dong-Young Noh. less Genes Chromosomes Cancer, 2008 Mar 05; 47(6). PMID: 18314908
Introducing molecular subtyping of breast cancer into the clinic? Therese Sørlie. J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204193
Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Zeng Quan Yang, Katie L Streicher, +2 authors, Michael E Ray, Judith Abrams, Stephen P Ethier. less Cancer Res, 2006 Dec 21; 66(24). PMID: 17178857
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Rachael Natrajan, Britta Weigelt, +10 authors, Jorge S Reis-Filho. less Breast Cancer Res Treat, 2009 Aug 19; 121(3). PMID: 19688261
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice. Bonnie Nannenga, Xiongbin Lu, +5 authors, Lawrence A Donehower. less Mol Carcinog, 2006 May 03; 45(8). PMID: 16652371
Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. F P O'Malley, S Chia, +5 authors, K I Pritchard. less J Natl Cancer Inst, 2009 Apr 30; 101(9). PMID: 19401546 Free PMC article.
Dual roles for the phosphatase PPM1D in regulating progesterone receptor function. David A Proia, Bonnie W Nannenga, Lawrence A Donehower, Nancy L Weigel. J Biol Chem, 2005 Dec 15; 281(11). PMID: 16352595
Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. Alison M Hosey, Julia J Gorski, +15 authors, D Paul Harkin. less J Natl Cancer Inst, 2007 Nov 15; 99(22). PMID: 18000219 Free PMC article.
A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Xiao-Jun Ma, Ranelle Salunga, +8 authors, Dennis Sgroi. less Clin Cancer Res, 2008 May 03; 14(9). PMID: 18451222
Targeted therapy for cancer using PARP inhibitors. Christopher J Lord, Alan Ashworth. Curr Opin Pharmacol, 2008 Jul 23; 8(4). PMID: 18644251 Highly Cited. Review.
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. Christos Sotiriou, Pratyaksha Wirapati, +17 authors, Mauro Delorenzi. less J Natl Cancer Inst, 2006 Feb 16; 98(4). PMID: 16478745 Highly Cited.
Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy. Fabrice Andre, Lajos Pusztai. Nat Clin Pract Oncol, 2006 Nov 03; 3(11). PMID: 17080180 Review.
Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013. Lyndsay N Harris, Gloria Broadwater, +11 authors, Lynn Dressler. less J Clin Oncol, 2009 May 28; 27(21). PMID: 19470942 Free PMC article.
A gene-expression signature as a predictor of survival in breast cancer. Marc J van de Vijver, Yudong D He, +18 authors, René Bernards. less N Engl J Med, 2002 Dec 20; 347(25). PMID: 12490681 Highly Cited.
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer. Edurne Arriola, Socorro Maria Rodriguez-Pinilla, +6 authors, Jorge S Reis-Filho. less Breast Cancer Res Treat, 2007 Jan 30; 106(2). PMID: 17260090
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Grazia Arpino, Valerie J Bardou, Gary M Clark, Richard M Elledge. Breast Cancer Res, 2004 Apr 16; 6(3). PMID: 15084238 Free PMC article. Highly Cited.
High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors. Elodie Manié, Anne Vincent-Salomon, +13 authors, Marc-Henri Stern. less Cancer Res, 2009 Jan 17; 69(2). PMID: 19147582
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Patrick W B Derksen, Xiaoling Liu, +11 authors, Jos Jonkers. less Cancer Cell, 2006 Nov 14; 10(5). PMID: 17097565 Highly Cited.
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. Sherene Loi, Benjamin Haibe-Kains, +16 authors, Christos Sotiriou. less BMC Genomics, 2008 May 24; 9. PMID: 18498629 Free PMC article. Highly Cited.
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Suet F Chin, Andrew E Teschendorff, +13 authors, Carlos Caldas. less Genome Biol, 2007 Oct 11; 8(10). PMID: 17925008 Free PMC article. Highly Cited.
gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation. C Adriana Bañuelos, Judit P Banáth, +2 authors, Peggy L Olive. less Clin Cancer Res, 2009 Apr 30; 15(10). PMID: 19401347
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Hannah Farmer, Nuala McCabe, +11 authors, Alan Ashworth. less Nature, 2005 Apr 15; 434(7035). PMID: 15829967 Highly Cited.
BRCA1 dysfunction in sporadic basal-like breast cancer. N C Turner, J S Reis-Filho, +8 authors, A N Tutt. less Oncogene, 2006 Oct 04; 26(14). PMID: 17016441 Highly Cited.
Lapatinib plus capecitabine for HER2-positive advanced breast cancer. Charles E Geyer, John Forster, +15 authors, David Cameron. less N Engl J Med, 2006 Dec 29; 355(26). PMID: 17192538 Highly Cited.
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components. Caterina Marchiò, Marjan Iravani, +13 authors, Jorge S Reis-Filho. less J Pathol, 2009 May 30; 218(3). PMID: 19479727
Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Roman Rouzier, Charles M Perou, +13 authors, Lajos Pusztai. less Clin Cancer Res, 2005 Aug 24; 11(16). PMID: 16115903 Highly Cited.
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Christine Desmedt, Benjamin Haibe-Kains, +6 authors, Christos Sotiriou. less Clin Cancer Res, 2008 Aug 14; 14(16). PMID: 18698033 Highly Cited.
Nestin is expressed in basal-like and triple negative breast cancers. S Parry, K Savage, C Marchiò, J S Reis-Filho. J Clin Pathol, 2008 Jul 22; 61(9). PMID: 18641405
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Lyndsay N Harris, Fanglei You, +12 authors, Eric P Winer. less Clin Cancer Res, 2007 Feb 24; 13(4). PMID: 17317830
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Anna V Ivshina, Joshy George, +12 authors, Lance D Miller. less Cancer Res, 2006 Nov 03; 66(21). PMID: 17079448 Highly Cited.
Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer. T A Järvinen, M Tanner, +2 authors, M Bärlund, A Borg, J Isola. less Genes Chromosomes Cancer, 1999 Sep 01; 26(2). PMID: 10469452
Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication. M B K Lambros, D S P Tan, +7 authors, J S Reis-Filho. less J Clin Pathol, 2009 Jun 30; 62(7). PMID: 19561229
Technology Insight: tuning into the genetic orchestra using microarrays--limitations of DNA microarrays in clinical practice. Ambreen Abdullah-Sayani, Jolien M Bueno-de-Mesquita, Marc J van de Vijver. Nat Clin Pract Oncol, 2006 Sep 07; 3(9). PMID: 16955089 Review.
Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. L G Fulford, D F Easton, +4 authors, A Hanby. less Histopathology, 2006 Jul 18; 49(1). PMID: 16842243
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. T Sørlie, C M Perou, +14 authors, A L Børresen-Dale. less Proc Natl Acad Sci U S A, 2001 Sep 13; 98(19). PMID: 11553815 Free PMC article. Highly Cited.
Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. S Droufakou, V Deshmane, +3 authors, R Roylance, A Hanby, I Tomlinson, I R Hart. less Int J Cancer, 2001 Apr 06; 92(3). PMID: 11291078
A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all? B Haibe-Kains, C Desmedt, C Sotiriou, G Bontempi. Bioinformatics, 2008 Jul 19; 24(19). PMID: 18635567 Free PMC article.
HER2 and responsiveness of breast cancer to adjuvant chemotherapy. Kathleen I Pritchard, Lois E Shepherd, +5 authors, National Cancer Institute of Canada Clinical Trials Group. less N Engl J Med, 2006 May 19; 354(20). PMID: 16707747 Highly Cited.
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Maggie C U Cheang, David Voduc, +5 authors, Torsten O Nielsen. less Clin Cancer Res, 2008 Mar 05; 14(5). PMID: 18316557 Highly Cited.
Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Kay Savage, Maryou B K Lambros, +11 authors, Jorge S Reis-Filho. less Clin Cancer Res, 2007 Jan 04; 13(1). PMID: 17200343
How basal are triple-negative breast cancers? François Bertucci, Pascal Finetti, +4 authors, Daniel Birnbaum. less Int J Cancer, 2008 Apr 10; 123(1). PMID: 18398844 Highly Cited.
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, +22 authors, FinHer Study Investigators. less N Engl J Med, 2006 Feb 24; 354(8). PMID: 16495393 Highly Cited.
The genomic profile of HER2-amplified breast cancers: the influence of ER status. C Marchiò, R Natrajan, +13 authors, J S Reis-Filho. less J Pathol, 2008 Sep 24; 216(4). PMID: 18810758
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q. Tom van Wezel, Marcel Lombaerts, +5 authors, Anne-Marie Cleton-Jansen. less Breast Cancer Res, 2005 Nov 11; 7(6). PMID: 16280054 Free PMC article.
Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? Felipe Correa Geyer, Jorge Sergio Reis-Filho. Int J Surg Pathol, 2008 Dec 24; 17(4). PMID: 19103611 Review.
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Lisa A Carey, Charles M Perou, +14 authors, Robert C Millikan. less JAMA, 2006 Jun 08; 295(21). PMID: 16757721 Highly Cited.
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis. Kay Savage, Samuel Leung, +8 authors, Jorge S Reis-Filho. less Breast Cancer Res Treat, 2007 Oct 04; 110(2). PMID: 17912630
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Xiongbin Lu, Bonnie Nannenga, Lawrence A Donehower. Genes Dev, 2005 May 05; 19(10). PMID: 15870257 Free PMC article. Highly Cited.
The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Jorge S Reis-Filho, Peter T Simpson, Theodora Gale, Sunil R Lakhani. Pathol Res Pract, 2005 Dec 06; 201(11). PMID: 16325514 Review.

Citedby
Next-generation sequencing. Jorge S Reis-Filho. Breast Cancer Res, 2010 Jan 20; 11 Suppl 3. PMID: 20030863 Free PMC article.
Transcriptomic landscape of breast cancers through mRNA sequencing. Jeyanthy Eswaran, Dinesh Cyanam, +7 authors, Rakesh Kumar. less Sci Rep, 2012 Feb 23; 2. PMID: 22355776 Free PMC article.
Involving disparate populations in clinical trials and biobanking protocols: experiences from the community network program centers. Beti Thompson, James R Hébert. Cancer Epidemiol Biomarkers Prev, 2014 Mar 13; 23(3). PMID: 24609845 Free PMC article.
Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications. Vida Pourteimoor, Samira Mohammadi-Yeganeh, Mahdi Paryan. Tumour Biol, 2016 Sep 22; 37(11). PMID: 27651157 Review.
The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges. Michaela Aubele, Manfred Schmitt, +8 authors, Marion Kiechle. less Dis Markers, 2017 Nov 16; 2017. PMID: 29138528 Free PMC article. Review.
Intellectual Structure and Evolutionary Trends of Precision Medicine Research: Coword Analysis. Xiaoguang Lyu, Jiming Hu, Weiguo Dong, Xin Xu. JMIR Med Inform, 2020 Feb 06; 8(2). PMID: 32014844 Free PMC article.
The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer. Vanessa Barriga, Nyanbol Kuol, Kulmira Nurgali, Vasso Apostolopoulos. Cancers (Basel), 2019 Aug 23; 11(8). PMID: 31430935 Free PMC article.

BioKDE: Biomedical Knowledge Discovery Engine

Abstract

Other Links